Sinergi Inti Andalan Prima Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Sinergi Inti Andalan Prima Tbk. trades at Rp224 (market cap 4.79T, 416.84M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp258 (market cap 678.4B, 25.57M 24h volume). The key difference: Sinergi Inti Andalan Prima Tbk. is far larger — about 7.1× Charlie Hospital Semarang Tbk.'s market cap, and Sinergi Inti Andalan Prima Tbk. is more actively traded (416.84M versus 25.57M). Which is the better fit depends on your goals.
| INET | RSCH | |
|---|---|---|
Market Cap | 4.79T | 678.4B |
Volume | 416.84M | 25.57M |
Lot | 4.17M | 255.67K |
Turnover | 93.24B | 6.57B |
Average Price | 223.69 | 256.8 |
Value | 93.24B | 6.57B |
Indicative Equilibrium Price | 224 | 258 |
Indicative Equilibrium Volume | 89.2K | 110 |
Trailing returns across standard periods
Latest headlines on both assets
PT Sinergi Inti Andalan Prima Tbk (the Company) was established on December 16, 2016 based on Notarial Deed No. 1 of Devi Prihartanti, S.H., notary in South Tangerang. The Company started its commercial operations in 2017.
Read more on INET →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →